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Abstract
Purpose Purpose of this feasibility study was (1) to eval-
uate whether application of ex-vivo 7T MR of the resected
tongue specimen containing squamous cell carcinoma may
provide information on the resection margin status and (2) to
evaluate the research and developmental issues that have to
be solved for this technique to have the beneficial impact on
clinical outcome that we expect: better oncologic and func-
tional outcomes, better quality of life, and lower costs.
Methods We performed a non-blinded validation of ex-
vivo 7T MR to detect the tongue squamous cell carcinoma
and resection margin in 10 fresh tongue specimens using
histopathology as gold standard.
Results In six of seven specimens with a histopathologically
determined invasion depth of the tumor of ≥3 mm, the tumor
could be recognized on MR, with a resection margin within
a 2 mm range as compared to histopathology. In three spec-
imens with an invasion depth of <1 mm, the tumor was not
visible on MR. Technical limitations mainly included scan
time, image resolution, and the fact that we used a less avail-
able small-bore 7T MR machine.
Conclusion Ex-vivo 7T probably will have a low negative
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predictive value but a high positive predictive value, meaning
that in tumors thicker than a few millimeters we expect to be
able to predict whether the resection margin is too small. A
randomized controlled trial needs to be performed to show
our hypothesis: better oncologic and functional outcomes,
better quality of life, and lower costs.
Keywords Magnetic resonance imaging · Ex-vivo ·
Tongue · Squamous cell carcinoma · Validation
Introduction
Tongue squamous cell carcinoma (TSCC) is the most com-
mon malignancy in the head and neck region and is primarily
treated surgically [1–5]. Goal of the surgical resection is to
completely remove the tumor with adequate resection mar-
gins, to avoid the need for subsequent additional treatment
such as repeated surgery or (chemo-) radiotherapy and to
minimize functional impairment related to the procedure.
Ultimately, optimizing the resection volume may result in
better oncologic and functional outcomes, better quality of
life, and lower costs [2].
The mucosal extension of the tumor usually can be evalu-
ated by visual inspection. Although definite information on
the deep resection margins requires postoperative histopatho-
logical analysis, peroperative information on the resection
margins could help to optimize resection volume. Unfortu-
nately, definite information on these resection margins is not
yet available during surgery [1,2]. Translation of informa-
tion from preoperative imaging into the actual situation in
the patient during surgery is challenging; macroscopic eval-
uation of a tumor in the tongue by palpation during surgery is
difficult and inaccurate, and peroperative biopsies or frozen
sections may suffer from sample error.
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MR imaging using ultrahigh field strengths of 7T and
above has recently been used to study healthy tissue ex-
vivo such as lymph nodes [6] as well as neoplasms such
as uveal melanoma [7], brain tumors [8,9], carcinoma of the
prostate [10–12], gastric and esophageal carcinoma [13–16]
and liver metastasis [17]. One study on breast carcinoma
patients using ex-vivo 1.5T MR [18] and one study on sar-
coma patients [19] specifically aimed at evaluation of the
resection margins, and one study using ex-vivo 1.5T MR
evaluated the depth of invasion of TSCC [20]. To the best
of our knowledge, this is the first study aiming at evaluating
the feasibility and validity of ex-vivo 7T MR for the novel
application of evaluation of resection margins in TSCC spec-
imens. Furthermore, we summarize the future research and
developmental improvements necessary for this technique to
have the beneficial impact on clinical outcome that we expect:
better oncologic and functional outcomes, better quality of
life, and lower costs.
Materials and methods
Study population
This study was initiated within the framework of the Rad-
boud University Medical Center MITeC initiative (Medical
Innovation & Technology expert Centre) [21]. Between
December 2013 and January 2015, ten patients with histo-
logically proven TSCC of the lateral tongue were included
prospectively, depending on anticipated immediate availabil-
ity of the 7T MR machine after surgery (5 females, 5 males,
age range 45–77 years). Patients received standard preop-
erative workup, surgery, and postoperative treatment when
indicated. Validation of ex-vivo 7T MR data with histopathol-
ogy was performed retrospectively after inclusion of the last
patient.
Preparation of the specimen before MR
Immediately after resection, the specimen was freshly trans-
ported at room temperature from the operating room to the
Department of Pathology. Preparation consisted of inking
and positioning the specimen with the largest resection plane
downward on a bed of paraffin inside a customized Perspex
holder that was optimized during the study with pins on both
sides of the holder 3 mm apart (except for the first patient).
The specimen then was fixed on the paraffin with wooden
pins or pipettes and the complete setup was positioned in a
glass container (Fig. 1).
MR examination
After preparation at the Department of Pathology, the spec-
imen was transported to the Preclinical Imaging Centre
(PRIME) of the Radboud University Medical Center [22].
The glass container with the specimen was filled with a per-
fluoropolyether oil (Galden, Solvay Solexis, Thorofare, NJ,
USA) to prevent susceptibility artefacts that would otherwise
be caused by interfaces between tissue and air.
Ex-vivo MR was performed on a Bruker ClinScan
horizontal-bore MR system, interfaced to a Siemens Syngo
VB15 console (Bruker BioSpin, Ettlingen, Germany). MR
images were recorded using an integrated circular polarized
transmit/receive 1H volume coil with a free inner diameter
of 154 mm. The scan protocol, which was optimized in one
specimen not included in this study, included T2-weighted
turbo spin-echo (T2-TSE) and one of two DWI HASTE
sequences with b-values of 0-100-500-1000-1200 s/mm2
(Table 1). Because of time restraints we did not include a 3D
T1-weighted sequence. ADC maps were calculated using the
standard postprocessing available in Siemens Syngo BV15.
To facilitate matching of the MR images and histopathology
slices, MR sequences were aligned to seven small water-filled
tubes in the holder to mark the center of the specimen. The
number of images was chosen to entirely cover the speci-
men front-to-back and repetition time and scan time were
changed accordingly. The protocol parameters were set as to
not exceed a total scan time of 1.5 h, including preparation
and positioning of the MR sequences.
Preparation of the specimen after MR
After the MR examination, the oil in the glass container was
disposed off and the specimen inside the glass container was
transported back to the Department of Pathology, formalin-
fixed overnight, and cut in 3-mm-thick slices from anterior
to posterior by using the pins in the holder 3 mm apart to
conduct the knife (Fig. 1). Digital photography of the gross
slices was performed. All slices were paraffin-embedded,
processed and 4-µm-thin tissue sections were cut and stained
with hematoxylin and eosin. The histopathological diagnoses
were classified according to the 2005 WHO criteria [23]. The
maximal invasion depth of the tumor and minimal resection
margin for the specimen were evaluated according to stan-
dard protocol.
Histopathological analysis
Histopathological examination was in no way hampered
by the ex-vivo MR procedure as no tissue changes have
been observed as compared to the routine procedure. Slices
were scanned with the 3DHistech Panoramic250 (SYSMEX
Belgium N.V., Hoeilaart, Belgium) and Olympus Dotslide
(Olympus Nederland B.V., Zoeterwoude, Netherlands). A
senior pathologist [CH] and a pathologist in training [EB]
together annotated tumor borders and the associated inflam-
matory infiltrate on each 4-µm-thin tissue section using
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Fig. 1 A specimen positioned
on a bed of paraffin inside a
specifically designed Perspex
holder (a, from above; b, from
aside), with pins on both sides
3 mm apart, then put into the
glass container (c, from aside).
In the middle, the holder
contains water-filled tubes to
facilitate matching between MR
images and histopathology
slices. The Perspex holder
evolved during the study to this
final configuration. After MR
examination, the oil in the glass
container was disposed off.
After formalin fixation, the
specimen was cut in 3-mm-thick
slices from anterior to posterior
using the pins in the holder and
totally included (d, from above)
Table 1 MR sequence parameters
Sequence Direction Number of
images
Slice
thickness
(mm)
Repetition
time (ms)
Echo time
(ms)
Averages Matrix Field of
view (mm)
Scan
time (ms)
T2-TSE Sagittal 20–40 1 3080–6150 67 1 256 × 256 50 × 50–54 × 54 1′51′′–3′42′′
T2-TSE Axial 25–52 1 3850–8610 13 1 256 × 256 50 × 50 2′19′′–5′11′′
T2-TSE Axial 25–52 1 3850–8610 54 1 256 × 256 50 × 50 2′19′′–5′11′′
T2-TSE Axial 9–20 3 2460–3070 54 1 256 × 256 50 × 50 1′28′′–1′51′′
DWI Axial 48–56 1 2000 54 4 128 × 128 34×34 6′24′′–7′28′′
DWI Axial 48–56 1 2130 54 4 128 × 128 50 × 50 6′49′′–7′57′′
For number of images, repetition time, field of view and scan time ranges are given; variations between specimens were caused by large variations
in volume of the specimens
T2-TSE turbo spin-echo T2-weighted sequence, DWI diffusion-weighted imaging
Aperio ImageScope v11.2.0.780 (Aperio Technologies, Inc.
Vista U.S.).
MR analysis and correlation to histopathology
Using the photographs of the 3-mm gross slices and anno-
tated 4-µm-thin tissue sections, evaluation of the tumor
on MR was performed in a non-blinded fashion by the
pathologist in training [EB] together with a head and neck
radiologist [SS]. Using integrated information from all MR
sequences available, maximal invasion depth and minimal
margin to the nearest resection plane were noted using a dig-
ital ruler.
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Table 2 Patient characteristics
and results from histopathology
(PA) and ex-vivo 7T MR (MR)
cTNM Invasion depth (mm) Resection margin (mm) Adjuvant treatment
PA MR PA MR
cT2 5.0 5.5 4.0 4.7 None (follow-up)
cT2 0.6 – 11.0 – None (follow-up)
cT1 8.0 7.7 0.6 1.1 RT (narrow resection
margin, infiltrating
growth pattern)
cT2 3.0 3.2 8.0 8.2 None (follow-up)
cT2 0.4 – 3.5 – None (follow-up)
cT2 4.5 3.8 2.0 2.4 RT (infiltrating growth
pattern)
cT2 3.0 3.6 4.0 4.1 RT (perineural
extension)
cT2 7.0 7.1 4.0 3.8 RT (infiltrating growth
pattern)
cT1 0.9 – 2.0 – None (follow-up)
cT4a 7.0 6.2 2.0 3.8 None (follow-up)
RT postoperative radiotherapy
Results
In six of seven specimens that showed an invasion depth of the
tumor of ≥3 mm at histopathology, the tumor could be recog-
nized and delineated on the combination of MR sequences. In
one of seven specimens with an invasion depth of the tumor
of ≥3 mm at histopathology, the tumor was visible on MR,
but delineation was difficult. In the three specimens with an
invasion depth of the tumor of <1 mm, the tumor was not
visible on MR. These specimens mainly contained dysplasia
with only minor invasive carcinoma components. In the spec-
imens where the tumor could be delineated, resection margin
as measured on MR was within a 2 mm range as compared
to histopathology (Table 2).
The lower resolution of MR as well as slight differences in
configuration of the specimen as compared to histopathology
caused different positioning of the measurements of invasion
depth and resection margins (Fig. 2). Although the margins
to the deep resection plane could be measured rather eas-
ily, exact identification of the mucosal resection plane on
MR was more difficult in three out of seven specimens. We
could not consistently recognize small bands of associated
inflammatory infiltrate on MR as depicted on histopathology
(Fig. 3). For individual sequences, signal intensity changes
as compared to the surrounding tissues were not consis-
tent.
Based on postoperative histopathological analysis and
according to the protocols, six out of ten patients did
not need additional treatment. In four out of ten patients,
histopathological tumor characteristics such as a perineural
or infiltrative growth pattern necessitated additional radio-
therapy (Table 2).
Discussion
To the best of our knowledge, this is the first study showing
the feasibility and validity of ex-vivo 7T MR for the novel
application of evaluation of resection margins in TSCC spec-
imens. The results of our study suggest that ex-vivo 7T is
expected to have a low negative predictive value, meaning
that it will be difficult to a) detect very small tumors and
b) predict that the resection margin is large enough given
the inability to visualize microscopic invasive growth pat-
terns. However, important is that we expect a high positive
predictive value, meaning that in tumors thicker than a few
millimeters we expect to be able to predict whether the resec-
tion margin is too small.
Overall, a good correlation existed between MR and
histopathology for minimal resection margin and maximal
depth of tumor invasion for TSCC specimens with an inva-
sion depth of ≥3 mm. This is in accordance with the only
previous ex-vivo study in TSCC specimens that we are aware
of, measuring maximal depth of tumor invasion on a 1.5T MR
[20]. Factors contributing to the observed differences in inva-
sion depth and resection margins in the current study include
the lower resolution of MR as compared to histopathology
(resulting in more difficult delineation of the tumor) and
slight differences in configuration of the specimen due to
deformability and effect of gravity in the Perspex holder.
Also, some shrinking of the specimen may have occurred
between MR and the final histopathological examination
[5]. These factors may hamper exact comparisons between
ex-vivo MR images and histopathology slices, which is of
utmost importance to prove that MR is accurate. We have
tried to overcome the problem by using a home-made Per-
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Fig. 2 Example of MR images of a specimen containing TSCC,
extending into the musculature. a 4 µm hematoxylin and eosin stained
histopathological section with tumor (green) and associated inflamma-
tory infiltrate (yellow) annotated (green marks from standard clinical
handling of the specimen), b DWI with b-value of 1000 s/m2 and slice
thickness of 1 mm, c T2-TSE with TE of 13 ms and slice thickness
of 1 mm, d ADC map. The TSCC is marked with arrows on b and
c. The slight difference in configuration of the specimen between MR
and histopathology is caused by gravity in the Perspex holder in the
MR machine. At all three MR images, the tumor can clearly be delin-
eated. At this histopathological section, the minimal resection margin
was measured (asterisk in a). However, the fissure at this location of
minimal resection margin at the histopathological section was not visi-
ble at MR due to lower resolution, and minimal resection margin at MR
would have been measured at a different section resulting in a slight dif-
ference. At the MR images, exact delineation of the mucosal resection
plane is difficult
Fig. 3 Example of MR images of three different specimens (a–c, d–
f and g–i). a–d–g T2-TSE with TE of 13 ms and slice thickness of
1 mm, b–e–h DWI sequence with b-value of 1000 s/m2 and slice thick-
ness of 1 mm; c–f–i corresponding 4 µm hematoxylin and eosin-stained
histopathological section with tumor (green) and tumor-related infil-
trate (yellow) annotated. The MR images show the differences in signal
intensity changes in different specimens, with the tumor clearly visible
in T2-TSE (a) and DWI (b) images in the first specimen, clearly visible
on T2-TSE image (d) but less conspicuous on DWI image (e) in the
second specimen, and more difficult to be recognized on T2-TSE (g)
than on DWI (h) in the third specimen. The tumor seems to be sepa-
rately recognizable from the associated inflammatory infiltrate in the
first specimen, but the infiltrate is too small to be recognized on the MR
images in the second and third specimen. As in the specimen in Fig. 2,
exact delineation of the mucosal resection plane on MR is difficult
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spex holder, aligning MR to water-filled tubes and using pins
inside which exactly fit the pathologists’ knife. Alignment
was not perfect and the technical setup has to be improved,
either by physical restraints of the specimen, or by rigid
and / or non-rigid registering of MR and histopathology
data by postprocessing software. However, exact compari-
son between ex-vivo MR images and histopathology slices
is important for validation of the technique only, as this will
not be necessary in clinical practice.
Since our ultimate goal is to provide the surgeon with
information on the resection margins during surgery, scan
times must be kept as low as possible. On the other hand, res-
olution must be optimized to increase the detection of small,
spiculated tumoral extensions as good as possible. In this
pilot study, we chose to use the high signal-to-noise ratio of
7T MR as compared to systems with lower field strengths to
acquire high-resolution images, at relatively low scan times
[24]. At present, however, the total time for transportation,
preparation and MR examination of the specimen was too
long for clinical application. Given the positive results of
this pilot study at a 7T MR system, we will now perform
a subsequent study on a clinical 3T MR system, which is
more widely available. In our institution, 3T MR is even
located in the operating theater, thereby significantly reduc-
ing transportation time. One of the main issues to overcome
the challenge to increase resolution and decrease scan time
will be to focus on performing one optimized T2-TSE and
one DWI sequence only.
We expect a clear advantage of the application of ex-vivo
MR on clinical outcome for part of our patients. By pro-
viding information on the resection margins during surgery,
ex-vivo MR may aid the surgeon in guiding peroperative
biopsies or frozen sections, and optimizing the resection. As
a result, the functional disability resulting from the resection
may decrease, as well as the need for repeated surgery or
postoperative (chemo-) radiotherapy, with a decrease in addi-
tional patient burden and costs to society. This may be true for
many other (soft tissue) tumors where clearance of resection
margins is of utmost importance and a one-step treatment
can increase quality of life as compared to a treatment with
repeated surgery or chemoradiotherapy. However, as stated
above, the strength of the technique will lie in the positive
predictive value predicting insufficient margins, and not in
the negative predictive value predicting that the tumor mar-
gins are sufficient. In either case, histopathology will always
be gold standard.
Disadvantages are mainly logistic. First, in those cases
without neck dissection or sentinel lymph node biopsy per-
formed during the MR examination, the patient will have
to be kept under general anesthesia just waiting on the MR
results. However, the vast majority of patients with TSCC
will undergo a procedure of the neck as well during which
MR can be performed. Second, an additional MR leads to
additional costs, although it is expected that these additional
costs will be largely outweighed by the savings from repeated
surgeries and additional (chemo-) radiotherapy.
Apart from the technical issues that have to be solved, lim-
itations were related to the explorative nature of this study.
First, the sample size was small. Second, the configuration
of the Perspex holder containing the specimen was not sim-
ilar for all specimens. The holder containing the specimen
was not anticipated but was developed during the study, as
we experienced difficulties in visually matching MR and
histopathological data in the first patients [17,25,26]. Third,
our study was non-blinded. We chose to first prove the tech-
nical feasibility of ex-vivo 7T MR to visualize the tumor and
learn to interpret the MR images, before evaluating the whole
pipeline.
Apart from the next steps to decrease scan time, to
increase resolution, and to implement the technique on a
3T machine, we have to optimize correlation of MR data
with histopathology to understand signal intensity changes
on specific sequences. For example, with increased resolu-
tion and optimized correlation with histopathology, we will
investigate whether histological features such as hemangio-
sis, lymphangiosis or perineural invasion has any influence
on the MR images. Unfortunately, the sample size of our cur-
rent study was too small to recognize specific patterns on the
specific sequences, and it was the combination of sequences
that led to identification of the tumor and resection margins
in most patients.
In all of these research and developmental innovations,
as a team mainly composed of clinical doctors we actively
seek collaborations with industrial partners and technical and
IT experts. We will perform a randomized controlled trial to
prove that the additional information on resection margins
during surgery actually leads to better functional outcomes
for the patient. Furthermore, we plan on making a direct com-
parison of ex-vivo MR and ex-vivo ultrasound. For unknown
reasons peroperative intraoral and ex-vivo ultrasound has not
gained wide application, although in the last decade some
promising results with respect to assessment of the TSCC
resection margin have been achieved [27–31].
In conclusion, in this study we have shown the feasibil-
ity and validity of ex-vivo 7T MR for the novel application
of evaluation of resection margins in TSCC specimens. The
results of our study suggest that ex-vivo 7T probably will
have a low negative predictive value but a high positive pre-
dictive value, meaning that in tumors thicker than a few
millimeters we expect to predict whether the resection mar-
gin is too small. We believe that this technique is close to
practical application, but a randomized controlled trial needs
to be performed to confirm our hypothesis that the technique
will provide better oncologic and functional outcomes, better
quality of life, and lower costs.
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